EVI5 Antikörper (Middle Region)
Kurzübersicht für EVI5 Antikörper (Middle Region) (ABIN952136)
Target
Alle EVI5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 230-259, Middle Region
-
Spezifität
- This antibody recognizes Human and Mouse EVI5 (Center).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 230~259 amino acids from the Center region of human EVI5
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- EVI5 (Ecotropic Viral Integration Site 5 (EVI5))
-
Andere Bezeichnung
- EVI5
-
Hintergrund
- EVI5 is a novel centrosomal protein with a complex expression pattern and subcellular localization, possibly involved in centrosome stability and dynamics. It may act as an oncogene.Synonyms: EVI-5, Ecotropic viral integration site 5 protein homolog, NB4S, Neuroblastoma stage 4S gene protein
-
Molekulargewicht
- 92935 Da
-
Gen-ID
- 7813
-
NCBI Accession
- NP_005656
Target
-